Skip to main content
OpenTrials

Clinical trial condition

Impact of SGLT2-inhibitors on PC-AKI in ACS Patients Receiving Invasive Strategy

Explore clinical trials studying Impact of SGLT2-inhibitors on PC-AKI in ACS Patients Receiving Invasive Strategy. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Impact of SGLT2-inhibitors on PC-AKI in ACS Patients Receiving Invasive Strategy trial results

Active, Not Recruiting

SGLT2-inhibitors on PC-AKI

NCT06491953

Conditions
Impact of SGLT2-inhibitors on PC-AKI in ACS Patients Receiving Invasive Strategy
Locations
  • General Hospital of Northern Theater Command Shenyang, Liaoning, China
View Trial Details